Stefan Janssens
Publications by Year
Research Areas
Nitric Oxide and Endothelin Effects, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Cardiac Fibrosis and Remodeling, Heart Failure Treatment and Management
Most-Cited Works
- → 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure(2021)12,270 cited
- → Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure(2020)4,820 cited
- → Empagliflozin in Heart Failure with a Preserved Ejection Fraction(2021)4,371 cited
- → Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)2,473 cited
- → Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies(2012)1,376 cited
- → Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial(2006)1,287 cited
- → The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial(2008)940 cited
- → The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial(2022)836 cited
- → Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase.(1992)605 cited
- → Myocardial ischemia-reperfusion injury and the influence of inflammation(2022)454 cited